المؤلفون: Ronald F van Vollenhoven, Sander W Tas, Taco W Kuijpers, Maarten Boers, Michael T Nurmohamed, Gertjan Wolbink, Irene E van der Horst-Bruinsma, Theo Rispens, Willem Lems, Alexandre Voskuyl, Carla A Wijbrandts, S Marieke van Ham, Martijn Gerritsen, Erik H Vogelzang, Luuk Wieske, Laura Boekel, Femke Hooijberg, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff

المصدر: RMD Open, Vol 8, Iss 1 (2022)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://rmdopen.bmj.com/content/8/1/e002035.full; https://doaj.org/toc/2056-5933

URL الوصول: https://doaj.org/article/c31dbe2993a2456ab42dc303970a81d9

المؤلفون: Laura Y Kummer, Sofie Keijzer, Erik H Vogelzang, Gertjan Wolbink, Laura Boekel, Luuk Wieske, Filip Eftimov, Maurice Steenhuis, Michael T Nurmohamed, Ronald van Vollenhoven, Gestur Vidarsson, T. Rispens, Koos P J van Dam, Joep Killestein, Olvi Cristianawati, S. Marieke van Ham, Zoé L.E. van Kempen, Yaëlle R Besten, Eileen W Stalman, Sander W. Tas, Alexandre E Voskuyl, Taco W. Kuijpers, Femke Hooijberg, Maarten Boers

المساهمون: SILS Other Research (FNWI), Rheumatology, AII - Inflammatory diseases, APH - Societal Participation & Health, Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical Microbiology and Infection Prevention, AII - Infectious diseases, Epidemiology and Data Science, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes, Graduate School, Landsteiner Laboratory, ANS - Neuroinfection & -inflammation, Clinical Immunology and Rheumatology, AMS - Musculoskeletal Health, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Experimental Immunology, EURO-NMD

المصدر: Boekel, L, Steenhuis, M, Hooijberg, F, Besten, Y R, van Kempen, Z L E, Kummer, L Y, van Dam, K P J, Stalman, E W, Vogelzang, E H, Cristianawati, O, Keijzer, S, Vidarsson, G, Voskuyl, A E, Wieske, L, Eftimov, F, van Vollenhoven, R, Kuijpers, T W, van Ham, S M, Tas, S W, Killestein, J, Boers, M, Nurmohamed, M T, Rispens, T & Wolbink, G 2021, ' Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands : a substudy of data from two prospective cohort studies ', The Lancet Rheumatology, vol. 3, no. 11, pp. e778-e788 . https://doi.org/10.1016/S2665-9913(21)00222-8, https://doi.org/10.1016/S2665-9913(21)00222-8
The Lancet. Rheumatology, 3(11), e778-e788. Elsevier Ltd
The Lancet. Rheumatology
The Lancet Rheumatology, 3(11), e778-e788. Lancet Publishing Group

مصطلحات موضوعية: medicine.medical_specialty, biology, business.industry, Multiple sclerosis, Immunogenicity, Immunology, Odds ratio, Articles, medicine.disease, Vaccination, Rheumatology, Internal medicine, medicine, biology.protein, Immunology and Allergy, Dosing, Antibody, Seroconversion, Prospective cohort study, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5058ec41cc875d2674bd64b83a76a66b
https://dare.uva.nl/personal/pure/en/publications/antibody-development-after-covid19-vaccination-in-patients-with-autoimmune-diseases-in-the-netherlands(036a10d7-30ae-4847-93fc-d95a956d1c63).html

المؤلفون: Eva M.M. Strijbis, A. ten Brinke, P. J. van Dam, Gertjan Wolbink, Alyssa A. Toorop, Sander W. Tas, Laura Y Kummer, Niels J. M. Verstegen, A. G. Volkers, Z.L.E. van Kempen, Mark Löwenberg, S. M. van Ham, Taco W. Kuijpers, T. Rispens, Joep Killestein, Laura Boekel, Luuk Wieske, Filip Eftimov, Maurice Steenhuis, C. E. van de Sandt, Eileen W Stalman

المساهمون: SILS Other Research (FNWI), Neurology, Experimental Immunology, Clinical Immunology and Rheumatology, AII - Inflammatory diseases, Landsteiner Laboratory, Gastroenterology and Hepatology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, ANS - Neuroinfection & -inflammation, EURO-NMD, Amsterdam Neuroscience - Neuroinfection & -inflammation, Gastroenterology and hepatology, Pediatrics, VU University medical center, Rheumatology, Pulmonary medicine, Pathology

المصدر: T2B! immunity against SARS-CoV-2 study group 2022, ' Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients : To wait and repopulate? ', Multiple Sclerosis and Related Disorders, vol. 57, 103416, pp. 103416 . https://doi.org/10.1016/j.msard.2021.103416
Multiple sclerosis and related disorders, 57:103416. Elsevier
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 57:103416. Elsevier
Multiple Sclerosis and Related Disorders, 57:103416. Elsevier
Multiple Sclerosis and Related Disorders

مصطلحات موضوعية: Booster vaccination, medicine.medical_specialty, COVID-19 Vaccines, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Antibodies, Monoclonal, Humanized, Article, Antibodies, MS, multiple sclerosis, Multiple sclerosis, Internal medicine, medicine, Humans, Ocrelizumab, Seroconversion, OCR, ocrelizumab, biology, business.industry, SARS-CoV-2, Vaccination, COVID-19, General Medicine, medicine.disease, DMT, disease modifying therapy, Neurology, biology.protein, Neurology (clinical), Antibody, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bce230db5b98b1f7713bab926997858
https://research.vumc.nl/en/publications/63937a74-3372-48c4-a013-8baffc018345

المؤلفون: Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink

المساهمون: Clinical Immunology and Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, Landsteiner Laboratory, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Neurology, ANS - Neuroinfection & -inflammation, Graduate School, Paediatrics, Experimental Immunology, EURO-NMD, Rheumatology, APH - Societal Participation & Health, Medical Microbiology and Infection Prevention, AMS - Tissue Function & Regeneration, ACS - Atherosclerosis & ischemic syndromes, Epidemiology and Data Science, APH - Methodology

المصدر: Rheumatic & Musculoskeletal Diseases Open, 8, 1
RMD open, 8(1):002035. BMJ Publishing Group
Rheumatic & Musculoskeletal Diseases Open, 8
RMD Open, 8(1):002035. BMJ Publishing Group
Boekel, L, Hooijberg, F, Vogelzang, E H, Besten, Y R, Leeuw, M, Atiqi, S, van Vollenhoven, R F, Wijbrandts, C A, Gerritsen, M, Krieckaert, C, Dijkshoorn, B, Bakhlakh, S, Crooijmans, J J, Voskuyl, A, van der Horst-Bruinsma, I E, Lems, W, Kuijpers, T W, van Ham, S M, Wieske, L, Eftimov, F, Kummer, L Y, van Dam, P K, Stalman, E W, Steenhuis, M, Keijzer, S, Cristianawati, O, Keijser, J, Loeff, F C, Tas, S W, Nurmohamed, M T, Boers, M, Rispens, T & Wolbink, G 2022, ' Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases : data from a prospective cohort study ', RMD Open, vol. 8, no. 1, 002035 . https://doi.org/10.1136/rmdopen-2021-002035

مصطلحات موضوعية: Adult, History, Polymers and Plastics, antirheumatic agents, SARS-CoV-2, Immunology, COVID-19, Severity of Illness Index, Industrial and Manufacturing Engineering, Rheumatology, biological therapy, Rheumatic Diseases, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Immunology and Allergy, Humans, autoimmune diseases, epidemiology, Prospective Studies, Business and International Management

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1435379ab158ca7d4c0cf06c2e660c43

المؤلفون: Ronald van Vollenhoven, S. Marieke van Ham, Femke Hooijberg, Joep Killestein, Maarten Boers, Laura Y Kummer, Theo Rispens, Koos P J van Dam, Sander W. Tas, Laura Boekel, Erik H Vogelzang, Zoé L. E. van Kempen, Taco W. Kuijpers, Michael T Nurmohamed, Luuk Wieske, Filip Eftimov, Gertjan Wolbink

المساهمون: Neurology, AII - Inflammatory diseases, ANS - Neuroinfection & -inflammation, Clinical Immunology and Rheumatology, AMS - Musculoskeletal Health, Landsteiner Laboratory, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, Experimental Immunology, EURO-NMD, Rheumatology, APH - Societal Participation & Health, Amsterdam Neuroscience - Neuroinfection & -inflammation, Medical Microbiology and Infection Prevention, Epidemiology and Data Science, APH - Methodology, ACS - Atherosclerosis & ischemic syndromes

المصدر: The Lancet Rheumatology, 3(8), e542-e545. Lancet Publishing Group
The Lancet. Rheumatology
Boekel, L, Kummer, L Y, van Dam, K P J, Hooijberg, F, van Kempen, Z, Vogelzang, E H, Wieske, L, Eftimov, F, van Vollenhoven, R, Kuijpers, T W, van Ham, S M, Tas, S W, Killestein, J, Boers, M, Nurmohamed, M T, Rispens, T & Wolbink, G 2021, ' Adverse events after first COVID-19 vaccination in patients with autoimmune diseases ', The Lancet Rheumatology, vol. 3, no. 8, pp. e542-e545 . https://doi.org/10.1016/S2665-9913(21)00181-8

مصطلحات موضوعية: medicine.medical_specialty, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunology, Comment, MEDLINE, Vaccination, Rheumatology, Internal medicine, medicine, Immunology and Allergy, In patient, Adverse effect, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6981c990e247bdb31efae77fbee23df
https://pure.amc.nl/en/publications/adverse-events-after-first-covid19-vaccination-in-patients-with-autoimmune-diseases(cef4a40f-a5ac-4214-b0cc-95bf93046c09).html

المؤلفون: Gertjan Wolbink, P. J. van Dam, Taco W. Kuijpers, Joep Killestein, Olfi Christianawati, Laura Boekel, Eileen W Stalman, Maurice Steenhuis, Theo Rispens, Sander W. Tas, Marieke van Ham, M. T. Nurmohamed, Sofie Keijzer, Laura Y Kummer, Zoé L.E. van Kempen, Gestur Vidarsson, Erik H Vogelzang, Yaëlle R Besten, Ronald F van Vollenhoven, Maarten Boers, Luuk Wieske, Filip Eftimov, Alexandre E. Voskuyl, Femke Hooijberg

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: medicine.medical_specialty, biology, business.industry, Antibody titer, Vaccination, Prednisone, Internal medicine, biology.protein, Medicine, Methotrexate, Seroconversion, Antibody, business, Prospective cohort study, medicine.drug, Cohort study

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3e566dfb1471b8c3c7b824f98985add6
https://doi.org/10.2139/ssrn.3869656